Integralis

Medical Care for Premature Infants

Health Tech & Life Sciences
Non Active, Apr 2022
Follow

Company Overview

Snapshot

Founded in January 2006 by Dan Sadeh Hochstadter, Integralis operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its AI diagnostic system for premature newborns.

Business overview

Integralis is a digital health company specializing in medical care for premature infants. The company has developed an AI diagnostic system designed to predict sepsis in premature newborns days before clinical symptoms manifest. Its core technology aims to detect late-onset sepsis 36 to 48 hours in advance, thereby improving patient outcomes, reducing hospitalization costs, and minimizing antibiotic use. Integralis operates within the Health Tech & Life Sciences sector, specifically targeting the digital healthcare and medical diagnostics markets with its B2B business model.

Log in to access full profile

Company Intelligence Q&A

What is Integralis' primary focus?
Integralis focuses on developing an AI diagnostic system for predicting sepsis in premature newborns, aiming to detect late-onset sepsis 36 to 48 hours before clinical symptoms appear.
When was Integralis founded?
Integralis was founded in January 2006.
Who is the founder of Integralis?
Dan Sadeh Hochstadter is the founder of Integralis.
What is the current employee size of Integralis?
Integralis currently has 1–10 employees.
What is the primary sector of Integralis?
Integralis operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Digital Medical Diagnostics.
Log in to access full profile